Allarity Therapeutics Inc (ALLR)

Name: Allarity Therapeutics Inc (ALLR) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Allarity Therapeutics Inc (ALLR)

Stock Card

$1.25

$-0.17 (-11.97%)

As on 08-Sep-2026 16:11EDT

Market cap

$23 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

6.4

Div. Yield

0 %

Allarity Therapeutics Inc (ALLR) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.25 High: 1.37

52 Week Range

Low: 0.77 High: 2.06

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.6 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0.1
Debt to Equity

0
Book Value

$--
EPS

$-0.8
Face value

--
Shares outstanding

15,910,724

7 Years Aggregate

CFO

$-97.95 Mln

EBITDA

$-82.89 Mln

Net Profit

$-74.08 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Allarity Therapeutics Inc (ALLR)	15.7	-10.1	-22.4	-36.5	-69.0	--	--
BSE Sensex^*	-11.5	-4.6	1.9	-7.3	4.0	5.2	9.9
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 08-Sep-2026 | *As on 09-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023
Allarity Therapeutics Inc (ALLR)	-7.7	-92.8	-99.9
S&P Small-Cap 600	4.0	7.0	13.9
BSE Sensex	9.1	8.1	18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Allarity Therapeutics Inc (ALLR)	1.3	22.6	0.4	-12.3	-2,488.1	-184.6	--	6.4
Arrowhead Pharmaceuticals (ARWR)	85.1	12,161.6	669.5	-320.0	-0.8	-71.1	--	26.2
Ascendis Pharma A/S - ADR	270.1	17,746.8	1,054.4	755.9	5.7	--	20.9	10.5
Cytokinetics Inc (CYTK)	75.4	10,109.8	71.0	-894.0	-1,175.8	--	--	60.5
Exelixis (EXEL)	57.7	14,621.6	2,435.9	860.6	31.0	43	18.6	7.9
Halozyme Therapeutics (HALO)	108.3	12,506.3	1,663.7	413.6	36.3	430	32.3	86.7
Krystal Biotech (KRYS)	351.3	10,603.5	440.5	241.5	33.4	18.7	44.9	8.1
Kymera Therapeutics (KYMR)	116.5	9,761.1	105.0	-299.7	-227.2	-19.4	--	6.5
Madrigal Pharmaceuticals (MDGL)	534.2	12,501.2	1,283.9	-325.1	-19.0	-57.7	--	23.9
Medpace Holdings (MEDP)	590.9	16,503.9	2,782.3	491.5	21.1	110.1	34.7	38.2

Shareholding Pattern

View Details

About Allarity Therapeutics Inc (ALLR)

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the... personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida. Read more

Founder, CEO & Director

Mr. Thomas H. Jensen
Founder, CEO, Senior VP of Investor Relations & Director

Mr. Thomas H. Jensen
Headquarters

Tarpon Springs, FL
Website

https://www.allarity.com

FAQs for Allarity Therapeutics Inc (ALLR)

What is the current share price of Allarity Therapeutics Inc (ALLR) Today?

The share price of Allarity Therapeutics Inc (ALLR) is $1.25 (NASDAQ) as of 08-Sep-2026 16:11 EDT. Allarity Therapeutics Inc (ALLR) has given a return of -69.01% in the last 3 years.

What is the current PB & PE ratio of Allarity Therapeutics Inc (ALLR)?

Since, TTM earnings of Allarity Therapeutics Inc (ALLR) is negative, P/E ratio is not available.
The P/B ratio of Allarity Therapeutics Inc (ALLR) is 6.39 times as on 04-Sep-2026, a 20 premium to its peers’ median range of 5.33 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-1.38	1.58
2024	-0.08	0.16
2023	0.00	0.00
2022	--	--
2021	--	--

What is the 52 Week High and Low of Allarity Therapeutics Inc (ALLR)?

The 52-week high and low of Allarity Therapeutics Inc (ALLR) are Rs 2.06 and Rs 0.77 as of 09-Sep-2026.

What is the market cap of Allarity Therapeutics Inc (ALLR)?

Allarity Therapeutics Inc (ALLR) has a market capitalisation of $ 23 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Allarity Therapeutics Inc (ALLR)?

Before investing in Allarity Therapeutics Inc (ALLR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.